Antitumor cell activity in glioblastoma is controlled by blocking the triggering receptor expressed on myeloid cells 2.

Published Date: 31 May 2023

The role of the TREM2 cell receptor/protein in glioblastoma is unknown, despite the fact that the importance of the triggering receptor expressed on myeloid cells 2 (TREM2) in brain microglial function during neurodegenerative diseases is well known.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Examines Office-Based Transperineal Prostate Biopsies Methodology.

2.

Atezolizumab Consolidation Impresses in High-Risk DLBCL

3.

AI could help improve early detection of interval breast cancers

4.

Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer

5.

Study identifies new target for obesity-related breast cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot